You have 9 free searches left this month | for more free features.

Condition

HIV (1)

Idiopathic CD4+ T-Lymphocytopenia (1)

Sepsis, Severe (1)

Umbilical Cord Blood Transplant (1)

Overall Status

Terminated (3)

Withdrawn (1)

Sign in for free

Phase

phase 1/phase 2 (2)

phase 2 (2)

Sponsor

Cytheris SA (1)

M.D. Anderson Cancer Center (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Revimmune (1)

Collaborator

George Clinical Pty Ltd (1)

National Cancer Institute (NCI) (1)

Revimmune (1)

University Hospital, Limoges (1)

Washington University School of Medicine (1)

Intervention

cyt107 (4)

placebos (1)

Study Documents

Intervention Type

drug (4)

biological (1)

Funder Type

Industry (2)

NIH (1)

Other (1)

Study Type

Interventional (4)

cyt107

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Sepsis, Severe Trial in France, United States (CYT107, Placebos)

Terminated

Sepsis, Severe

CYT107
Placebos

Gainesville, Florida
+9 more

Oct 19, 2021

Umbilical Cord Blood Transplant Trial (CYT107)

Withdrawn

Umbilical Cord Blood Transplant

CYT107

(no location specified)

Jan 8, 2019

Idiopathic CD4+ T-Lymphocytopenia Trial run by the NIAID (CYT107)

Terminated

Has Results

Idiopathic CD4+ T-Lymphocytopenia

CYT107

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Oct 14, 2015

HIV Trial in Milano, Johannesbourg, Zurich (CYT107)

Terminated

HIV

CYT107

Milano, Italy
+2 more

Jul 24, 2013